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ABSTRACT 
The aim of this study was to investigate the chemical constituents of Lindera erythrocarpa essential oil (LEO) by 
gas chromatography-mass spectrometry and evaluate their inhibitory effect on the expression of pro-inflammatory 
mediators in lipopolysaccharide (LPS)-stimulated RAW264.7 cells. Fifteen compounds, accounting for 63.7 % of 
the composition of LEO, were identified. The main compounds were nerolidol (18.73 %), caryophyllene 
(14.41 %), α-humulene (7.73 %), germacrene-D (4.82 %), and α-pinene (4.47 %). LEO significantly inhibited the 
expression of inducible nitric oxide (NO) synthase and cyclooxygenase-2, and subsequent production of NO and 
prostaglandin E2. In addition, it reduced the release of pro-inflammatory cytokines in LPS-activated RAW264.7 
cells. The molecular mechanism underlying the effect of LEO was associated with inhibition of the phosphoryla-
tion of mitogen-activated protein kinase (MAPK). Furthermore, LEO inhibited LPS-induced phosphorylation and 
degradation of inhibitor of kappa B-α, which is required for the activation of the p50 and p65 nuclear factor (NF)-
κB subunits in RAW264.7 cells. Taken together, these data suggest that LEO exerted its anti-inflammatory effect 
by downregulating LPS-induced production of pro-inflammatory mediators through the inhibition of NF-κB and 
MAPK signaling in RAW264.7 cells. 
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INTRODUCTION 
Prolonged inflammation is involved in the 
pathogenesis of a variety of diseases, includ-
ing pulmonary fibrosis, atherosclerosis, 
chronic hepatitis, rheumatoid arthritis, and in-
flammatory brain diseases (Chung et al., 
2007). Inflammation is caused by pro-inflam-
matory mediators, including both pro-inflam-
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matory cytokines such as tumor necrosis fac-
tor (TNF)-α, interleukin (IL)-1β, and IL-6, 
and pro-inflammatory factors such as nitric 
oxide (NO), prostaglandin E2 (PGE2), induci-
ble nitric oxide synthase (iNOS), and cy-
clooxygenase (COX)-2 (Ljung et al., 2006; 
Walsh et al., 2005). Therefore, inhibition of 
these inflammatory mediators is an important 
target pathway in the treatment of diseases 
with anti-inflammatory components.  
Nuclear transcription factor kappa-B (NF-
κB) regulates a variety of genes associated 
with immune and acute-phase inflammatory 
responses. The activation of NF-κB due to 
pro-inflammatory stimulation is indicated by 
rapid phosphorylation and degradation of in-
hibitors of kappa B (IκBs) (Rajapakse et al., 
2008). Freed NF-κB dimers from this process 
translocate to the nucleus and bind to the pro-
moter regions of target genes (Lee et al., 
2003). They then induce the transcription of 
pro-inflammatory mediators such as iNOS, 
COX-2, IL-6, IL-1β, and TNF-α (Makarov, 
2000; Yoshimura, 2006). Recent studies have 
reported that the anti-inflammatory effect of 
phytochemicals occurs through blocking of 
the NF-κB signaling pathway (Ham et al., 
2015; Hsieh et al., 2011). Mitogen-activated 
protein kinases (MAPKs) are one of the major 
kinases involved in cellular processes such as 
apoptosis, stress responses, differentiation, 
and immune defense (Liu et al., 2007). 
MAPKs comprise three major subgroups, 
namely, p38 MAPKs, c-Jun N-terminal ki-
nases (JNKs), and extracellular signal-regu-
lated kinases (ERKs). Their activation plays 
an important role in the expression of iNOS 
and COX-2 and in the production of cytokines 
(Rajapakse et al., 2008; Rao, 2001). There-
fore, MAPK and NF-κB may be effective as 
anti-inflammatory agents. 
Lindera erythrocarpa is widely distrib-
uted in the Republic of Korea, Japan, and 
China (Sun and Chung, 1988). Lindera spe-
cies, including L. strychnifolia, L. lucida, L. 
chunii, and L. aggregate are important medic-
inal plants. The fruit and leaves of L. erythro-
carpa are used in folk medicine for treating 
digestive disorders, thirst, pain, and neuralgia. 
They are also used as antidotes and diuretics 
(Hong et al., 2009; Oh et al., 2005; Sun and 
Chung, 1988). Recently, L. erythrocarpa was 
reported to suppress adipogenesis and mela-
nin synthesis, attenuate obesity, as well as ex-
hibit antioxidant, anti-inflammatory, and an-
tifungal activities (Hsieh and Wang, 2013; 
Hwang et al., 2007; Kumar et al., 2010; Wang 
et al., 2008). Essential oils extracted from me-
dicinal and aromatic plants are known to have 
biological effects, most notably anti-inflam-
matory, antioxidant, antifungal, and antibac-
terial activities (Chaieb et al., 2007; Pinheiro 
et al., 2011). These properties are a driving in-
terest in the use of essential oils in the cos-
metic, pharmaceutical, and food industries 
(Chaieb et al., 2007; Lang and Buchbauer, 
2012; Tumen et al., 2010). However, the 
mechanism by which L. erythrocarpa essen-
tial oil (LEO) exerts its anti-inflammatory ef-
fect has not been elucidated. Therefore, in this 
study, we examined the anti-inflammatory ef-
fects of LEO and its constituents on lipopoly-
saccharide (LPS)-stimulated RAW264.7 
cells. 
 
MATERIALS AND METHODS 
Reagents 
LPS, phosphate buffered saline (PBS), di-
methyl sulfoxide (DMSO), 3-(4,5-dimethyl-
thiazol-2-yl)-2,5-diphenyltetrazolium bro-
mide (MTT) and radio-immunoprecipitation 
assay RIPA lysis buffer were bought from 
Sigma–Aldrich (St. Louis, MO, USA). Fetal 
bovine serum (FBS) and Dulbecco’s modified 
Eagle’s medium (DMEM) were purchased 
from Invitrogen-Gibco (Grand Island, NY, 
USA). Enzyme-linked immunosorbent assay 
(ELISA) kits for the analyses of TNF-α, IL-6, 
and PGE2 were obtained from BD Biosci-
ences (San Diego, CA, USA) and R&D Sys-
tems, Inc. (St. Louis, MO, USA). Antiphos-
phorylated IκB-α (anti-p-IκB-α), anti-NF-κB, 
anti-JNK, anti-p38, anti-ERK1/2, anti-phos-
phorylated JNK (anti-p-JNK), anti-phosphor-
ylated p38 (anti-p-p38) and anti-phosphory-
lated ERK1/2 (anti-p-ERK1/2) mouse or rab-
bit antibodies were bought from Cell Signal-
ing Technology (Beverly, MA, USA). All 
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other reagents were obtained from Sigma-Al-
drich. 
 
Extraction of essential oil from the leaves 
of L. erythrocarpa 
The leaves of L. erythrocarpa were col-
lected from Namwon (a region in Jeju Island, 
Korea) in May 2014 and LEO was extracted 
by hydrodistillation. Briefly, approximately 
300 g of fresh L. erythrocarpa leaves was im-
mersed in 3 l of distilled water in a 5-l flask. 
Subsequently, the obtained essential oil was 
dried over anhydrous sodium sulfate, filtered, 
and stored in a sealed vial at 4 °C until tested. 
The LEO yield was approximately 0.067 % 
(v/w). 
 
Gas chromatography (GC)-mass spectrome-
try (MS) analysis 
Analysis of the main components of the 
most active essential oil extracted from L. 
erythrocarpa leaves was carried out using a 
GC (Agilent 6890, Agilent Technologies Inc., 
Santa Clara, CA, USA) connected to an MS 
(Agilent 5975). The GC was equipped with a 
DB1-HT column (30 m × 0.32 mm; 0.1 µm 
film thickness). The oven temperature was 
programmed to increase from 40 to 100°C at 
a rate of 2 °C/min, and then from 100 to 
230 °C at a rate of 5 °C/min, after which it 
was held at 230 °C for 5 min. The detector 
and injector temperatures were 280 °C and 
240 °C, respectively. The flow rate of the car-
rier gas (He) was 1.5 ml/min and the split ratio 
was 1:10. For the sample injection (split less), 
10 μl of LEO was diluted in 500 μl of CH2Cl2 
and 1 μl of this solution was injected for anal-
ysis. Identification of the compounds was 
done by comparison of their mass spectra 
with reference spectra in  the Wiley libraries. 
The GC-MS retention indices were also cal-
culated using a homologous series of n-al-
kanes (C6-C31). 
 
Cell culture 
The murine macrophage cell line 
RAW264.7 (Korean Cell Line Bank, Seoul, 
Korea) was cultured in DMEM (100 U/ml 
penicillin, 100 μg/ml streptomycin and 10 % 
FBS) in an atmosphere of 5 % CO2 at 37 °C 
and were subcultured every 3 days. 
 
Cell viability assay 
The cytotoxicity of LEO against 
RAW264.7 cells was examined via an MTT 
assay. RAW264.7 cells (1.8 × 105 cells/ml) 
were plated in 96-well plates for 24 h and then 
treated with aliquots of LEO at 37 C for 24 h. 
MTT solution was added to each well for 4 h. 
The plates were centrifuged at 2000 rpm for 
10 min, and the supernatants were removed 
by aspiration. The formazan crystals in each 
well were dissolved in DMSO and absorbance 
was measured at 540 nm. 
 
Determination of NO production 
RAW264.7 cells (1.8 × 105 cells/ml) were 
plated in 24 well-plates for 24 h and then cul-
tured with LPS (1 μg/ml) in the absence or 
presence of LEO (0.01 %, 0.02 %, and 
0.04 %) for 24 h. The amount of nitrite that 
accumulated in the culture medium was meas-
ured and used as an indicator of NO produc-
tion. Briefly, 100 μl of cell culture medium 
was mixed with an equal volume of 1 X 
Griess reagent, and incubated at room temper-
ature for 10 min. Absorbance was then meas-
ured at 540 nm. A fresh culture medium was 
used as the blank in every experiment.  
 
ELISA assay  
Sandwich ELISA was used to determine 
the inhibitory effects of 0.01 %, 0.02 %, and 
0.04 % of LEO on the production of PGE2, 
TNF-α, and IL-6 in LPS-stimulated 
RAW264.7 cells. The analyses were done us-
ing the relevant ELISA kits according to the 
manufacturer’s instructions. The cells were 
stimulated for 24 h before the supernatant was 
harvested and assayed. 
 
Western blot analysis  
RAW264.7 cells were treated with LPS in 
the absence or presence of the aforementioned 
concentration of LEO. After incubation, the 
cells were washed twice with cold PBS and 
lysed in RIPA lysis buffer. The cell lysates 
were then isolated by centrifugation at 15,000 
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rpm for 15 min at 4 ^°C. Protein concentra-
tion in the supernatants was measured by the 
Bradford assay (Bio-Rad, Hercules, CA, 
USA) and all proteins were adjusted to an 
equal protein content. Aliquots of the lysates 
(20~30 μg protein/lane) were separated on a 
NuPAGE 4-12 % bis-Tris gel (Invitrogen, 
Carlsbad, CA, USA) and the separated pro-
teins were transferred onto polyvinylidene 
difluoride (PVDF) membranes using an iBlot 
gel transfer device (Invitrogen). The mem-
branes were immersed in 5 % non-fat skim 
milk, which was used as a blocking solution 
and incubated with primary antibodies 
(1:1,000) at 4 °C for 24 h. After incubating, 
the membranes were washed several times 
with Tween 20-Tris-buffered saline and incu-
bated with secondary horseradish peroxidase-
linked anti-rabbit or anti-mouse IgG (1:5,000, 
Cell Signaling Technology) for 90 min. After 
washing, immunoactive proteins were de-
tected using the WEST-ZOL (plus) Western 
Blot Detection System (iNtRON Biotechnol-
ogy, Gyeonggi, Korea). 
 
Statistical analysis  
All data have been reported as mean ± 
standard deviation. Statistical analyses of the 
data were using Student’s t-test. P values less 
than 0.05 were considered to be statistically 
significant. 
 
RESULTS 
Chemical composition and cytotoxicity of 
LEO 
The chemical composition and retention 
indices of the constituents of LEO are pre-
sented in Table 1 and Figure 1. A total of 15 
volatile constituents were identified, repre-
senting 63.73 % of the composition of LEO. 
The main constituents of LEO were nerolidol 
(18.73 %), caryophyllene (14.41 %), α-hu-
mulene (7.73 %), germacrene-D (4.82 %), 
and α-pinene (4.47 %). We initially con-
ducted a cytotoxicity test via an MTT assay 
(Figure 2A) and found that LEO (0.01, 0.02, 
and 0.04 %) was not cytotoxic to the 
RAW264.7 cells; therefore, we used the oil at 
concentrations of 0.01-0.04 % in subsequent 
experiments. 
 
Effects of LEO on the production of NO 
and PGE2 in LPS-stimulated RAW264.7 
cells 
We investigated the potential anti-inflam-
matory effect of LEO by evaluating the pro-
duction of NO and PGE2 in LPS-stimulated 
RAW264.7 cells. As shown in Figure 2B, NO 
production was substantially higher in LPS-
treated cells than in the untreated cells. How-
ever, LEO suppressed NO production in the 
LPS-treated cells in a dose-dependent man-
ner. Addition of 0.04 % LEO to the cells 
caused a reduction in LPS-induced NO pro-
duction by 86.1 %. Moreover, results of the 
PGE2 assays revealed a significant dose-de-
pendent inhibition of PGE2 production by 
LEO in the LPS-activated cells. PGE2 produc-
tion was inhibited by 54.1, 65.8, and 71.8 % 
by LEO at concentrations of 0.01, 0.02, and 
0.04 %, respectively (Figure 2C). 
 
Effects of LEO on the expression of iNOS 
and COX-2 in LPS-stimulated RAW264.7 
cells 
Western blot analyses were used to deter-
mine whether the inhibitory activity of LEO 
on the production of NO and PGE2 was re-
lated to the expression levels of iNOS and 
COX-2. The data shown in Figure 3 demon-
strate that the expression levels of iNOS and 
COX-2 in the LPS-stimulated cells increased 
when compared with the untreated control. 
However, LEO (0.01, 0.02, and 0.04 %) in-
hibited LPS-induced increases in iNOS and 
COX-2 levels in a dose-dependent manner. 
These results are consistent with the inhibi-
tory effects of LEO on the production of NO 
and PGE2. 
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Table 1: Chemical composition of the essential oil from Lindera erythrocarpa 
No RT (min) Constituent Peak area (%) 
1 6.881 3-Hexen-1-ol 0.39 
2 8.998 α-Pinene 4.47 
3 9.570 Camphene 3.03 
4 10.726 β-Pinene 1.76 
5 11.447 β-Myrcene 0.92 
6 13.026 Dl-Limonene 0.61 
7 14.004 β-Ocimene 2.23 
8 16.791 β-Linalool 0.67 
9 24.052 Geraniol 0.73 
10 25.265 Bornyl  acetate 2.56 
11 30.570 Caryophyllene 14.41 
12 31.966 α-Caryophyllene 7.34 
13 33.087 Germacrene-D 4.82 
14 34.787 δ-Cadinene 1.05 
15 36.704 Nerolidol 18.73 
 Total identified 63.73 
RT, retention time  
Components were identified by comparison of their mass spectra in the GC-MS library (Wiley 138)  
 
 
Figure 1: GC-MS total ion chromatogram of the essential oil of LEO. The compound labels in the chro-
matogram correspond to the Arabic numerals given in Table 1. 
 
 
Effects of LEO on the production of IL-6 
and TNF-α in LPS-stimulated RAW264.7 
cells 
We further investigated the effects of 
LEO on the secretion of IL-6 and TNF-α in 
LPS-activated RAW264.7 cells. As shown in 
Figure 4, the production of IL-6 and TNF-α 
was considerably increased by LPS but signif-
icantly inhibited by LEO in a dose-dependent 
manner.  
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Figure 2: Effect of LEO on NO and PGE2 produc-
tion in LPS-induced RAW264.7 cells. Cells (1.8 × 
105 cells/ml) were stimulated by LPS (1 μg/μl) for 
24h in the presence of LEO (0.01, 0.02, and 0.04 
%). (A) Cytotoxicity of LEO was assessed by 
MTT. Supernatants were collected, and the (B) 
NO and (C) PGE2 concentration in the superna-
tants was determined using Griess reaction and 
the enzyme immunoassay, respectively. Values 
are expressed as means ± S.D. of triplicate exper-
iments.  
 
Figure 3: Effects of LEO on production of iNOS 
and COX-2 protein in LPS-induced RAW264.7 
cells. RAW264.7 cells (1.8 × 105 cells/ml) were 
pre-incubated for 18 h, and the cells were stimu-
lated with LPS (1 μg/μl) in the presence of LEO 
(0.01, 0.02, and 0.04 %) for 24 h. iNOS and COX-
2 protein levels were determined via Western blot 
method.  
 
 
 
Figure 4: Effect of LEO on IL-6 and TNF-α pro-
duction in LPS-induced RAW264.7 cells. Cells 
(1.8 × 105 cells/ml) were stimulated by LPS (1 
μg/μl) for 24 h in the presence of LEO (0.01, 0.02, 
and 0.04 %). Supernatants were collected, and 
the IL-6 and TNF-α concentration in the superna-
tants was determined by ELISA. Values are ex-
pressed as means ± S.D. of triplicate experi-
ments.  
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Effect of LEO on the NF-κB signaling 
pathway in LPS-activated RAW264.7 cells 
Since the phosphorylation of IκB and its 
subsequent degradation are essential steps in 
NF-κB activation by LPS, we examined the 
effect of LEO on these processes in a Western 
blot analysis. Our results showed that LEO 
significantly decreased the phosphorylation 
and degradation of IκB-α in the LPS-activated 
cells (Figure 5). NF-κB plays a critical role in 
the inflammatory response; therefore, we fur-
ther investigated whether LEO blocks NF-κB 
activation in LPS-stimulated cells. Our results 
showed that LEO dose-dependently inhibited 
LPS-induced NF-κB activation. These find-
ings suggest that LEO attenuates NF-κB acti-
vation by inhibiting IκB-α degradation, which 
further inhibits the expression of inflamma-
tory mediators.  
 
 
Figure 5: Effect of LEO on phosphorylation of NF-
κB in LPS-induced RAW264.7 cells. RAW264.7 
cells (1.8 × 106 cells/ml) were pre-incubated for 
18 h, and the cells were stimulated with LPS 
(1 μg/μl) in the presence of LEO (0.01, 0.02, and 
0.04 %) for 30 min. The levels of p-p50, p 50, p-
IκB-α and IκB-α were determined using Western 
blot method.  
 
 
Effects of LEO on the phosphorylation of 
MAPKs in LPS-activated RAW264.7 cells 
We investigated by Western blotting 
whether inhibition of the expression of pro-
inflammatory mediators by LEO is mediated 
by the MAPK pathway. The results indicated 
that LEO inhibited LPS-induced phosphory-
lation of JNK, p38, and ERK in a concentra-
tion-dependent manner (Figure 6). These 
findings suggest that the anti-inflammatory 
activity of LEO is mediated by inhibition of 
LPS-induced phosphorylation of MAPKs. 
 
 
Figure 6: Effect of LEO on phosphorylation of 
MAPK in LPS-induced RAW264.7 cells. 
RAW264.7 cells (1.8 × 106 cells/ml) were pre-in-
cubated for 18 h, and the cells were stimulated 
with LPS (1 μg/μl) in the presence of LEO (0.01, 
0.02, and 0.04 %) for 30 min. The levels of p-ERK, 
ERK, p-JNK, JNK, p-p38 and p38 were deter-
mined using Western blot method. 
 
DISCUSSION 
The results of the study demonstrate that 
LEO exhibits significant inhibitory effects on 
the expression of pro-inflammatory mediators 
such as NO, PGE2, iNOS, COX-2, IL-6, and 
TNF-α. These effects were accompanied by 
inhibition of the phosphorylation of MAPKs 
and NF-κB.  
Nerolidol, the major component of the es-
sential oil of Peperomia serpens, has been 
shown to inhibit carrageenan-induced paw 
and ear edema in mice (Pinheiro et al., 2011). 
Fonseca et al. (2016) demonstrated the anti-
inflammatory effect of nerolidol via its inhi-
bitions of carrageenan-induced paw edema 
formation and LPS-stimulated IL-6 and IL-1β 
production in peritoneal macrophages. Fur-
thermore, the anti-inflammatory activities of 
α-humulene and (-)-trans-caryophyllene have 
been demonstrated via their inhibition of the 
production of different inflammatory media-
tors in carrageenan-treated rats (Fernandes et 
al., 2007). In addition, other minor com-
pounds present in LEO, such as α-pinene, β-
pinene, β-myrcene, dl-limonene, geraniol, 
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and bornyl acetate, have  been shown to ex-
hibit anti-inflammatory activities (Chen and 
Viljoen, 2010; d'Alessio et al., 2013; Rufino 
et al., 2014, 2015; Wu et al., 2004). Therefore, 
the anti-inflammatory activity of LEO could 
be attributed to its major constituents or a syn-
ergetic action among the constituents present 
in the oil. 
Macrophages are activated by LPS pro-
duce pro-inflammatory factors, such as NO, 
PGE2, iNOS, and COX-2 (Korhonen et al., 
2005). For this reason, we selected LPS as an 
inflammatory stimulant for the study. The 
production of NO by iNOS due to stimulation 
with LPS plays an important role in inflam-
mation (McCann et al., 2005). Similar to NO, 
PGE2 is an inflammatory mediator generated 
at inflammatory sites by COX-2, which is in-
volved in the pathogenesis of many chronic 
inflammatory diseases, such as rheumatoid 
arthritis, cancer, and cardiovascular disease 
(Lipsky, 1999; Rocca and FitzGerald, 2002). 
Thus, reducing the levels of NO, PGE2, iNOS, 
and COX-2 may be an attractive target for 
confirming anti-inflammatory effects. In ad-
dition, the pro-inflammatory cytokines IL-1β, 
IL-6, and TNF-α are known to contribute to 
inflammatory diseases, such as pulmonary fi-
brosis, atherosclerosis, chronic hepatitis, 
rheumatoid arthritis, and inflammatory brain 
diseases (Chung et al., 2007). Hence, we 
measured the effects of LEO on the expres-
sion of iNOS and COX-2 and the production 
of NO, PGE2, IL-6, and TNF-α in LPS-stim-
ulated RAW264.7 cells. Pretreatment of the 
cells with LEO inhibited the production of 
NO and PGE2 by reducing LPS-induced ex-
pression of iNOS and COX-2. Moreover, 
LEO reduced LPS-induced TNF-α and IL-6 
production. Other studies have similarly re-
ported that the anti-inflammatory effect of es-
sential oils is associated with the suppression 
of mediators such as PGE2, NO, IL-6, TNF-α, 
COX-2, and iNOS (Yoon et al., 2010a, b).  
MAPKs are the major components of the 
signaling pathway that leads to the expression 
of pro-inflammatory mediators. Moreover, it 
is known that MAPKs play an important role 
in inflammatory signaling in LPS-stimulated 
macrophages (Hommes et al., 2003; Nakano 
et al., 1998). Furthermore, p38 is involved in 
the transcriptional regulation of pro-inflam-
matory mediators, including iNOS, COX-2, 
and TNF-α, in LPS-induced macrophage re-
sponses (Bhat et al., 1998). In addition, the 
phosphorylation of ERK is thought to be im-
plicated in the increased production of pro-in-
flammatory cytokines and iNOS in LPS-in-
duced macrophage responses (Ajizian et al., 
1999; Bhat et al., 1998). Other studies have 
reported that JNK is primarily implicated in 
the expression of iNOS and COX-2 in LPS-
stimulated macrophages (Chan and Riches, 
1998; Uto et al., 2005). Therefore, we as-
sessed the MAPK signaling pathway to eluci-
date the mechanism underlying the anti-in-
flammatory effect of LEO in LPS-activated 
macrophages. The results showed that pre-
treatment with LEO resulted in a significant 
suppression of JNK, ERK, and p38 phosphor-
ylation in the LPS-activated macrophages. 
NF-κB is a mammalian transcription fac-
tor that regulates many genes, including those 
involved the expression of iNOS, COX-2, 
TNF-α, IL-1β, and IL-6, which are important 
in immune and inflammatory responses in 
LPS-stimulated macrophages (Barnes and 
Karin, 1997). In unstimulated cells, NF-κB is 
present as a quiescent form bound to the in-
hibitory protein IκB in the cytosol (Karin and 
Ben-Neriah, 2000). Upon stimulation with 
LPS, IκB is degraded, which permits the nu-
clear translocation of the NF-κB complex, 
where it binds kb sites and activates the gene 
transcription of iNOS, COX-2, and other pro-
inflammatory cytokines (Surh et al., 2001). In 
our studies, LEO attenuated IκB-α degrada-
tion and suppressed NF-κB activation in LPS-
stimulated RAW264.7 cells. This suggests 
that it inhibits the activation of inflammatory 
mediators by blocking the NF-κB signaling 
pathway during the activation of macro-
phages. 
In conclusion, the anti-inflammatory ac-
tivity of LEO is evidenced by its inhibition of 
the production of NO, PGE2, and other cyto-
kines (e.g., TNF-α and IL-6) via regulation of 
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the NF-κB and MAPK pathways. These re-
sults suggest that the development of sub-
stances that modulate the expression of pro-
inflammatory mediators can provide a molec-
ular basis for developing functional foods for 
the treatment of various inflammatory dis-
eases.  
 
Conflict of interest 
The authors have no competing financial 
interests to declare. 
 
Acknowledgments 
This work was supported by the Korea 
Basic Science Institute (C37965) and 
(C37260). 
 
REFERENCES 
Ajizian SJ, English BK, Meals EA. Specific inhibitors 
of p38 and extracellular signal-regulated kinase 
mitogen-activated protein kinase pathways block 
inducible nitric oxide synthase and tumor necrosis 
factor accumulation in murine macrophages stimulated 
with lipopolysaccharide and interferon-gamma. J 
Infect Dis. 1999;179:939-44. 
Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal 
transcription factor in chronic inflammatory diseases. 
N Engl J Med. 1997;336:1066-71. 
Bhat NR, Zhang P, Lee JC, Hogan EL. Extracellular 
signal-regulated kinase and p38 subgroups of mitogen-
activated protein kinases regulate inducible nitric oxide 
synthase and tumor necrosis factor-alpha gene 
expression in endotoxin-stimulated primary glial 
cultures. J Neurosci. 1998;18:1633-41. 
Chaieb K, Hajlaoui H, Zmantar T, Kahla-Nakbi AB, 
Rouabhia M, Mahdouani K, et al. The chemical 
composition and biological activity of clove essential 
oil, Eugenia caryophyllata (Syzigium aromaticum L. 
Myrtaceae): a short review. Phytother Res. 2007;21: 
501-6. 
Chan ED, Riches DW. Potential role of the JNK/SAPK 
signal transduction pathway in the induction of iNOS 
by TNF-alpha. Biochem Biophys Res Commun. 1998; 
253:790-6. 
Chen W, Viljoen AM. Geraniol - A review of a 
commercially important fragrance material. S Afr J 
Botany. 2010;76:643-51. 
Chung CP, Avalos I, Raggi P, Stein CM. Athero-
sclerosis and inflammation: insights from rheumatoid 
arthritis. Clin Rheumatol. 2007;26:1228-33. 
d'Alessio PA, Ostan R, Bisson J-F, Schulzke JD, Ursini 
MV, Béné MC. Oral administration of d-Limonene 
controls inflammation in rat colitis and displays anti-
inflammatory properties as diet supplementation in 
humans. Life Sci. 2013;92:1151-6. 
Fernandes ES, Passos GF, Medeiros R, da Cunha FM, 
Ferreira J, Campos MM, et al. Anti-inflammatory 
effects of compounds alpha-humulene and (-)-trans-
caryophyllene isolated from the essential oil of Cordia 
verbenacea. Eur J Pharmacol. 2007;569:228-36. 
Fonseca DV, Salgado PR, de Carvalho FL, Salvadori 
MG, Penha AR, Leite FC, et al. Nerolidol exhibits 
antinociceptive and anti-inflammatory activity: 
involvement of the GABAergic system and proinflam-
matory cytokines. Fund Clin Pharmacol. 2016;30:14-
22. 
Ham Y-M, Ko Y-J, Song S-M, Kim J, Kim K-N, Yun 
J-H, et al. Anti-inflammatory effect of litsenolide B2 
isolated from Litsea japonica fruit via suppressing NF-
κB and MAPK pathways in LPS-induced RAW264.7 
cells. J Functional Foods. 2015;13:80-8. 
Hommes DW, Peppelenbosch MP, van Deventer SJ. 
Mitogen activated protein (MAP) kinase signal 
transduction pathways and novel anti-inflammatory 
targets. Gut. 2003;52:144-51. 
Hong H-K, Yoon W-J, Kim YH, Yoo E-S, Jo S-H. 
Inhibition of the Human Ether-a-go-go-related Gene 
(HERG) K(+) Channels by Lindera erythrocarpa. J 
Korean Med Sci. 2009;24:1089-98. 
Hsieh IN, Chang AS, Teng CM, Chen CC, Yang CR. 
Aciculatin inhibits lipopolysaccharide-mediated 
inducible nitric oxide synthase and cyclooxygenase-2 
expression via suppressing NF-kappaB and JNK/p38 
MAPK activation pathways. J Biomed Sci. 2011;18: 
28. 
Hsieh YH, Wang SY. Lucidone from Lindera 
erythrocarpa Makino fruits suppresses adipogenesis in 
3T3-L1 cells and attenuates obesity and consequent 
metabolic disorders in high-fat diet C57BL/6 mice. 
Phytomedicine. 2013;20:394-400. 
Hwang EI, Lee YM, Lee SM, Yeo WH, Moon JS, 
Kang TH, et al. Inhibition of chitin synthase 2 and 
antifungal activity of lignans from the stem bark of 
Lindera erythrocarpa. Planta Med. 2007;73:679-82. 
Karin M, Ben-Neriah Y. Phosphorylation meets 
ubiquitination: the control of NF-[kappa]B activity. 
Annu Rev Immunol. 2000;18:621-63. 
Korhonen R, Lahti A, Kankaanranta H, Moilanen E. 
Nitric oxide production and signaling in inflammation. 
Curr Drug Targets Inflamm Allergy. 2005;4:471-9. 
EXCLI Journal 2017;16:1103-1113 – ISSN 1611-2156 
Received: June 26, 2017, accepted: August 17, 2017, published: August 29, 2017 
 
 
1112 
Kumar KJ, Yang JC, Chu FH, Chang ST, Wang SY. 
Lucidone, a novel melanin inhibitor from the fruit of 
Lindera erythrocarpa Makino. Phytother Res. 2010;24: 
1158-65. 
Lang G, Buchbauer G. A review on recent research 
results (2008–2010) on essential oils as antimicrobials 
and antifungals. A review. Flav Fragrance J. 2012;27: 
13-39. 
Lee SJ, Bai SK, Lee KS, Namkoong S, Na HJ, Ha KS, 
et al. Astaxanthin inhibits nitric oxide production and 
inflammatory gene expression by suppressing 
I(kappa)B kinase-dependent NF-kappaB activation. 
Mol Cells. 2003;16:97-105. 
Lipsky PE. The clinical potential of cyclooxygenase-2-
specific inhibitors. Am J Med. 1999;106:51S-7S. 
Liu Y, Shepherd EG, Nelin LD. MAPK phosphatases-
-regulating the immune response. Nat Rev Immunol. 
2007;7:202-12. 
Ljung T, Lundberg S, Varsanyi M, Johansson C, 
Schmidt PT, Herulf M, et al. Rectal nitric oxide as 
biomarker in the treatment of inflammatory bowel 
disease: responders versus nonresponders. World J 
Gastroenterol. 2006;12:3386-92. 
Makarov SS. NF-kappaB as a therapeutic target in 
chronic inflammation: recent advances. Mol Med 
Today. 2000;6:441-8. 
McCann SM, Mastronardi C, de Laurentiis A, Rettori 
V. The nitric oxide theory of aging revisited. Ann N Y 
Acad Sci. 2005;1057:64-84. 
Nakano H, Shindo M, Sakon S, Nishinaka S, Mihara 
M, Yagita H, et al. Differential regulation of IkappaB 
kinase alpha and beta by two upstream kinases, NF-
kappaB-inducing kinase and mitogen-activated protein 
kinase/ERK kinase kinase-1. Proc Natl Acad Sci U S 
A. 1998;95:3537-42. 
Oh H-M, Choi S-K, Lee JM, Lee S-K, Kim H-Y, Han 
DC, et al. Cyclopentenediones, inhibitors of farnesyl 
protein transferase and anti-tumor compounds, isolated 
from the fruit of Lindera erythrocarpa Makino. Bioorg 
Med Chem. 2005;13:6182-7. 
Pinheiro BG, Silva AS, Souza GE, Figueiredo JG, 
Cunha FQ, Lahlou S, et al. Chemical composition, 
antinociceptive and anti-inflammatory effects in 
rodents of the essential oil of Peperomia serpens (Sw.) 
Loud. J Ethnopharmacol. 2011;138:479-86. 
Rajapakse N, Kim MM, Mendis E, Kim SK. Inhibition 
of inducible nitric oxide synthase and cyclooxygenase-
2 in lipopolysaccharide-stimulated RAW264.7 cells by 
carboxybutyrylated glucosamine takes place via down-
regulation of mitogen-activated protein kinase-
mediated nuclear factor-kappaB signaling. Immunol-
ogy. 2008;123:348-57. 
Rao KM. MAP kinase activation in macrophages. J 
Leukoc Biol. 2001;69:3-10. 
Rocca B, FitzGerald GA. Cyclooxygenases and 
prostaglandins: shaping up the immune response. Int 
Immunopharmacol. 2002;2:603-30. 
Rufino AT, Ribeiro M, Judas F, Salgueiro L, Lopes 
MC, Cavaleiro C, et al. Anti-inflammatory and 
chondroprotective activity of (+)-alpha-pinene: 
structural and enantiomeric selectivity. J Nat Prod. 
2014;77:264-9. 
Rufino AT, Ribeiro M, Sousa C, Judas F, Salgueiro L, 
Cavaleiro, C, et al. Evaluation of the anti-
inflammatory, anti-catabolic and pro-anabolic effects 
of E-caryophyllene, myrcene and limonene in a cell 
model of osteoarthritis. Eur J Pharmacol. 2015;750: 
141-50. 
Sun BY, Chung YH. Monbographic study of the 
Lauracea in Korea. Korean J Plant Tax. 1988;18:133-
51. 
Surh YJ, Chun KS, Cha HH, Han SS, Keum YS, Park 
KK, et al. Molecular mechanisms underlying 
chemopreventive activities of anti-inflammatory 
phytochemicals: down-regulation of COX-2 and iNOS 
through suppression of NF-kappa B activation. Mutat 
Res. 2001;480-481:243-68. 
Tumen I, Hafizoglu H, Kilic A, Donmez IE, Sivrikaya 
H, Reunanen M. Yields and constituents of essential oil 
from cones of Pinaceae spp. natively grown in Turkey. 
Molecules. 2010;15:5797-806. 
Uto T, Fujii M, Hou DX. 6-(Methylsulfinyl)hexyl 
isothiocyanate suppresses inducible nitric oxide 
synthase expression through the inhibition of Janus 
kinase 2-mediated JNK pathway in lipopoly-
saccharide-activated murine macrophages. Biochem 
Pharmacol. 2005;70:1211-21. 
Walsh NC, Crotti TN, Goldring SR, Gravallese EM. 
Rheumatic diseases: the effects of inflammation on 
bone. Immunol Rev. 2005;208:228-51. 
Wang SY, Lan XY, Xiao JH, Yang JC, Kao YT, Chang 
ST. Antiinflammatory activity of Lindera erythrocarpa 
fruits. Phytother Res. 2008;22:213-6. 
EXCLI Journal 2017;16:1103-1113 – ISSN 1611-2156 
Received: June 26, 2017, accepted: August 17, 2017, published: August 29, 2017 
 
 
1113 
Wu X, Li X, Xiao F, Zhang Z, Xu Z, Wang H. [Studies 
on the analgesic and anti-inflammatory effect of bornyl 
acetate in volatile oil from Amomum villosum]. (in 
Chin.). Zhong Yao Cai. 2004;27:438-9. 
Yoon WJ, Moon JY, Kang JY, Kim GO, Lee NH, 
Hyun CG. Neolitsea sericea essential oil attenuates 
LPS-induced inflammation in RAW 264.7 macro-
phages by suppressing NF-kappaB and MAPK 
activation. Nat Prod Commun. 2010a;5:1311-6. 
Yoon WJ, Moon JY, Song G, Lee YK, Han MS, Lee 
JS, et al. Artemisia fukudo essential oil attenuates LPS-
induced inflammation by suppressing NF-kappaB and 
MAPK activation in RAW 264.7 macrophages. Food 
Chem Toxicol. 2010b;48:1222-9. 
Yoshimura A. Signal transduction of inflammatory 
cytokines and tumor development. Cancer Sci. 2006; 
97:439-47. 
 
